Generics Approvals Will Decline, US FDA Predicts, But Supplement Work May Grow

 
• By Derrick Gingery
  
Generics
Record ANDA supplement receipts pushed predictions of related actions in FY 2020 and FY 2021 to record levels. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics